Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 3.776B
March 31, 2026 3.540B
December 31, 2025 3.678B
September 30, 2025 3.600B
June 30, 2025 3.423B
March 31, 2025 3.365B
December 31, 2024 3.501B
September 30, 2024 3.461B
June 30, 2024 3.510B
March 31, 2024 3.456B
December 31, 2023 3.473B
September 30, 2023 3.687B
June 30, 2023 3.701B
March 31, 2023 3.627B
December 31, 2022 3.799B
September 30, 2022 3.874B
June 30, 2022 4.041B
March 31, 2022 3.889B
December 31, 2021 3.940B
September 30, 2021 3.974B
June 30, 2021 4.023B
March 31, 2021 3.960B
December 31, 2020 4.006B
September 30, 2020 4.038B
June 30, 2020 4.057B
Date Value
March 31, 2020 4.391B
December 31, 2019 3.666B
September 30, 2019 3.704B
June 30, 2019 4.262B
March 31, 2019 4.385B
December 31, 2018 4.353B
September 30, 2018 4.582B
June 30, 2018 4.545B
March 31, 2018 0.00
December 31, 2017 1.342B
September 30, 2017
June 30, 2017
March 31, 2017 1.696B
December 31, 2016 1.823B
September 30, 2016 2.120B
June 30, 2016 1.850B
March 31, 2016 1.886B
December 31, 2015 1.922B
September 30, 2015 1.996B
June 30, 2015 2.032B
March 31, 2015 1.782B
December 31, 2014 1.080B
September 30, 2014 1.092B
June 30, 2014 1.059B
March 31, 2014 982.20M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 521.92M
Eli Lilly & Co. 142.28B
Indivior Pharmaceuticals, Inc. 1.233B
Viatris, Inc. 35.04B
Pfizer Inc. 201.13B

Total Assets (Quarterly) Related Metrics